Elacestrant dihydrochloride

Elacestrant dihydrochloride (sold as Orserdu) is an oral Selective Estrogen Receptor Degrader (SERD) approved to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. It is indicated for postmenopausal women and men whose disease progressed after endocrine therapy, acting by binding to and degrading estrogen receptors

A Anant Labs fabrica e fornece impurezas de Elacestrant dihydrochloride de alta qualidade para o mercado global. Nossas impurezas EP de Elacestrant dihydrochloride são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.